{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:23Z","timestamp":1789685063065,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.tmaid.2007.07.004","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T10:35:14Z","timestamp":1190111714000},"page":"327-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Preventing rabies with the Verorab\u00ae vaccine: 1985\u20132005"],"prefix":"10.1016","volume":"5","author":[{"given":"Stephen","family":"Toovey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/clinids\/20.4.818","article-title":"Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants","volume":"20","author":"Chutivongse","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib2","first-page":"1023","article-title":"Human antirabies vaccine from pasteur to the present","volume":"179","author":"Barme","year":"1995","journal-title":"Bull Acad Nat Med"},{"issue":"6","key":"10.1016\/j.tmaid.2007.07.004_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(89)90050-9","article-title":"Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells","volume":"7","author":"Ajjan","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2007.07.004_bib5","series-title":"Improvements in rabies post-exposure treatment","first-page":"123","article-title":"Compatibility and immunogenicity of Merieux's purified vero rabies vaccine (PVRV) in healthy subjects","author":"Svjetlicic","year":"1985"},{"key":"10.1016\/j.tmaid.2007.07.004_bib6","series-title":"Improvements in rabies post-exposure treatment","first-page":"115","article-title":"A new vaccine produced from Rabies virus cultivated on Vero cell","author":"Fournier","year":"1985"},{"issue":"8499","key":"10.1016\/j.tmaid.2007.07.004_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(86)91946-X","article-title":"New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals","volume":"2","author":"Suntharasamai","year":"1986","journal-title":"Lancet"},{"issue":"9413","key":"10.1016\/j.tmaid.2007.07.004_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(04)15792-9","article-title":"Rabies and other lyssavirus diseases","volume":"363","author":"Warrell","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib9","first-page":"229","article-title":"Human rabies","volume":"3","author":"Hattwick","year":"1974","journal-title":"Public Health Rev"},{"issue":"6","key":"10.1016\/j.tmaid.2007.07.004_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.7326\/0003-4819-76-6-931","article-title":"Recovery from rabies. A case report","volume":"76","author":"Hattwick","year":"1972","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/344905","article-title":"Management of rabies in humans","volume":"36","author":"Jackson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.tmaid.2007.07.004_bib12","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2007.07.004_bib13","first-page":"1","volume":"824","year":"1992","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib14","first-page":"41","article-title":"Immune response of suckling mouse brain (CRL) rabies vaccine and tissue culture rabies vaccine (Verorab) in pre-exposure prophylaxis in humans","volume":"132","author":"Favi","year":"2004","journal-title":"Rev Med Chile"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1086\/313632","article-title":"Rabies","volume":"30","author":"Plotkin","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0035-9203(87)90234-3","article-title":"Antibody response to suckling mouse brain rabies vaccines for post exposure treatment","volume":"81","author":"Chanthavanich","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"16","key":"10.1016\/j.tmaid.2007.07.004_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0264-410X(96)00090-4","article-title":"Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine","volume":"14","author":"Khawplod","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1086\/514931","article-title":"Postexposure treatment of rabies in Pakistan","volume":"27","author":"Parviz","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.tmaid.2007.07.004_bib19","first-page":"667","article-title":"Neurological complications due to Semple-type antirabies vaccine. Clinical and therapeutic aspects","volume":"39","author":"Swamy","year":"1991","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","article-title":"Neurological adverse events associated with vaccination","volume":"15","author":"Piyasirisilp","year":"2002","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.tmaid.2007.07.004_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM198702123160703","article-title":"Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination","volume":"316","author":"Hemachudha","year":"1987","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.38.1.42","article-title":"Immunological studies of patients with chronic encephalitis induced by post-exposure Semple Rabies vaccine","volume":"38","author":"Hemachudha","year":"1988","journal-title":"Neurology"},{"issue":"2\u20133","key":"10.1016\/j.tmaid.2007.07.004_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-510X(90)90127-9","article-title":"Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases","volume":"96","author":"Chaleomchan","year":"1990","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0035-9203(88)90167-8","article-title":"A high rate of neurological complications following Semple anti-rabies vaccine","volume":"82","author":"Swaddiwuthipong","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib25","first-page":"526","article-title":"A high incidence of neurological complications following Semple anti-rabies vaccine","volume":"18","author":"Swaddiwudhipong","year":"1987","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"10","key":"10.1016\/j.tmaid.2007.07.004_bib26","first-page":"491","article-title":"Neurological complications in adults given post-exposure Semple-type rabies vaccine","volume":"25","author":"Bahri","year":"1996","journal-title":"Press Med"},{"key":"10.1016\/j.tmaid.2007.07.004_bib27","unstructured":"WHO Expert Consultation on Rabies. First report 931, WHO technical report series 13-7-2005. Geneva, Switzerland: WHO; 2005. p. 1\u2013121."},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib28","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"23","key":"10.1016\/j.tmaid.2007.07.004_bib29","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.vaccine.2004.12.008","article-title":"The real cost of rabies post-exposure treatments","volume":"23","author":"Goswami","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2007.07.004_bib30","unstructured":"WHO Expert Committee on Rabies. Seventh report 709. WHO technical report series. Geneva, Switzerland: WHO; 1984."},{"issue":"Suppl","key":"10.1016\/j.tmaid.2007.07.004_bib31","first-page":"30","article-title":"Rabies as a traveller's risk, especially in high-endemicity areas","volume":"12","author":"Meslin","year":"2005","journal-title":"J Travel Med"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib32","first-page":"41","article-title":"Rabies and post-exposure prophylaxis in Thai children","volume":"7","author":"Thongcharoen","year":"1989","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2004.05.003","article-title":"Common dilemmas in managing rabies exposed subjects","volume":"3","author":"Sriaroon","year":"2005","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2007.07.004_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0022172400066286","article-title":"Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens","volume":"96","author":"Suntharasamai","year":"1986","journal-title":"J Camb Hyg"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1708-8305.1999.tb00525.x","article-title":"Economic issues in postexposure rabies treatment","volume":"6","author":"Wilde","year":"1999","journal-title":"J Travel Med"},{"issue":"9066","key":"10.1016\/j.tmaid.2007.07.004_bib36","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(96)10085-4","article-title":"Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants","volume":"349","author":"Lang","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0035-9203(99)90309-7","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial","volume":"93","author":"Lang","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8498","key":"10.1016\/j.tmaid.2007.07.004_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(86)91624-7","article-title":"Rabies vaccine for human use, cultivated on Vero cells","volume":"2","author":"Dureux","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.tmaid.2007.07.004_bib40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00006454-199811000-00007","article-title":"Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine","volume":"17","author":"Sabchareon","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.tmaid.2007.07.004_bib41","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/jcm.28.8.1847-1850.1990","article-title":"Comparison of human immune responses to purified Vero cell and human diploid cell rabies vaccines by using two different antibody titration methods","volume":"28","author":"Kitala","year":"1990","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib42","first-page":"26","article-title":"Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value","volume":"26","author":"Hacibektasoglu","year":"1992","journal-title":"Mikrobiyol Bul"},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib43","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1998","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0035-9203(88)90539-1","article-title":"One year booster vaccination with purified vero cell rabies vaccine","volume":"82","author":"Suntharasamai","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4269\/ajtmh.1987.36.160","article-title":"Early antibody responses to rabies post-exposure vaccine regimens","volume":"36","author":"Suntharasamai","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2007.07.004_bib46","series-title":"Improvements in rabies post-exposure treatment","first-page":"129","article-title":"Study of the efficacy of a vaccine produced from rabies virus cultivated on Vero cell","author":"Chadli","year":"1985"},{"issue":"16","key":"10.1016\/j.tmaid.2007.07.004_bib47","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0264-410X(98)00045-0","article-title":"Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial)","volume":"16","author":"Jaiiaroensup","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib48","first-page":"287","article-title":"Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China","volume":"31","author":"Wang","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0001-706X(98)00038-2","article-title":"Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine","volume":"70","author":"Lang","year":"1998","journal-title":"Acta Trop"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib50","first-page":"23","article-title":"Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population","volume":"29","author":"Seghal","year":"1997","journal-title":"J Commun Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2007.07.004_bib51","first-page":"229","article-title":"Post-exposure prophylaxis with purified vero cell rabies vaccine during pregnancy-safety and immunogenicity","volume":"31","author":"Sudarshan","year":"1999","journal-title":"J Commun Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib52","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/513760","article-title":"Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations","volume":"25","author":"Kositprapa","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","author":"Vodopija","year":"1997","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.tmaid.2007.07.004_bib54","first-page":"1609","article-title":"Post-exposure antirabies vaccination. Early serological response to vaccine cultivated on VERO cells using a reduced 2-1-1 schedule","volume":"23","author":"Colnot","year":"1994","journal-title":"Press Med"},{"issue":"8","key":"10.1016\/j.tmaid.2007.07.004_bib55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(91)90244-Z","article-title":"One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine","volume":"9","author":"Chutivongse","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib56","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group","volume":"76","author":"Lang","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2007.07.004_bib57","series-title":"Vaccines","first-page":"1011","article-title":"Rabies vaccine","author":"Plotkin","year":"2004"},{"issue":"8694","key":"10.1016\/j.tmaid.2007.07.004_bib58","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib59","first-page":"33","article-title":"Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine","volume":"5","author":"Phanuphak","year":"1987","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7060.2002.23189","article-title":"Four-site intradermal postexposure boosters in previously rabies vaccinated subjects","volume":"9","author":"Khawplod","year":"2002","journal-title":"J Travel Med"},{"issue":"17\u201318","key":"10.1016\/j.tmaid.2007.07.004_bib61","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0264-410X(02)00111-1","article-title":"Potency, sterility and immunogenicity of rabies tissue culture vaccine after reconstitution and refrigerated storage for 1 week","volume":"20","author":"Khawplod","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib62","first-page":"83","article-title":"What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?","volume":"68","author":"Phanuphak","year":"1990","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.tmaid.2007.07.004_bib63","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.1982.03320330034022","article-title":"Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses","volume":"247","author":"Bernard","year":"1982","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.tmaid.2007.07.004_bib64","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0264-410X(89)90280-6","article-title":"Postexposure rabies vaccination during pregnancy: experience with 21 patients","volume":"7","author":"Chutivongse","year":"1989","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib65","first-page":"76","article-title":"Post exposure rabies prophylaxis with Purified Verocell Rabies Vaccine: a study of immunoresponse in pregnant women and their matched controls","volume":"43","author":"Sudarshan","year":"1999","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.tmaid.2007.07.004_bib66","first-page":"13","article-title":"Post-exposure antirabies prophylaxis in pregnant women","volume":"62","author":"Figueroa","year":"1994","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.tmaid.2007.07.004_bib67","series-title":"Rabies control in Asia","first-page":"97","article-title":"Dose-related antibody responses to purified Vero cell rabies vaccine in healthy Thai children","author":"Chanthavanich","year":"1997"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/313610","article-title":"Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1","volume":"30","author":"Thisyakorn","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2007.07.004_bib69","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/003655401750174183","article-title":"Failure of pre- and postexposure rabies vaccinations in a child infected with HIV","volume":"33","author":"Pancharoen","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/517179","article-title":"Additional reports of failure to respond to treatment after rabies exposure in Thailand","volume":"28","author":"Hemachudha","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2007.07.004_bib71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2007.07.004_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00019048-199808000-00008","article-title":"Rabies post exposure prophylaxis: when is it appropriate?","volume":"7","author":"Kreindel","year":"1998","journal-title":"Infect Dis Clin Practice"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib73","first-page":"41","article-title":"Rabies and post-exposure prophylaxis in Thai children","volume":"7","author":"Thongcharoen","year":"1989","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.tmaid.2007.07.004_bib74","unstructured":"Systemic allergic reactions following immunization with human diploid cell rabies vaccine. Morb Mortal Wkly Rep 1984;33(14):185\u20137."},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0091-6749(85)90151-4","article-title":"Serum sickness like reaction associated with skin-sensitizing antibody following booster dose of rabies human-diploid cell vaccine","volume":"75","author":"Deutsch","year":"1985","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.tmaid.2007.07.004_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0264-410X(86)90096-4","article-title":"Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine","volume":"4","author":"Dreesen","year":"1986","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tmaid.2007.07.004_bib77","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0091-6749(87)80278-6","article-title":"The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine","volume":"80","author":"Anderson","year":"1987","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.tmaid.2007.07.004_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/101053958800200308","article-title":"Acceptability and efficacy of purified Vero-cell rabies vaccine in Thai children exposed to rabies","volume":"2","author":"Chutivongse","year":"1988","journal-title":"Asia Pac J Public Health"},{"issue":"7\u20138","key":"10.1016\/j.tmaid.2007.07.004_bib79","first-page":"675","article-title":"Systemic allergic reactions after immunization with human-diploid cell rabies vaccine","volume":"18","year":"1984","journal-title":"Drug IntellClin Pharm"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893907000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893907000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:57:09Z","timestamp":1761487029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893907000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1477893907000610"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2007.07.004","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing rabies with the Verorab\u00ae vaccine: 1985\u20132005","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2007.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}